📰 Sandra Vedrick News
Sandra Vedrick News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sandra Vedrick. Real-time updates on events, politics, business and more.
February 6, 2024
SAN DIEGO--(BUSINESS WIRE)--#biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today announced the closing on February 5, 2024 of its previously anno...
November 14, 2023
SAN DIEGO--(BUSINESS WIRE)--#biotechnews--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three and nine months ended September 30, 2023 fin...
August 12, 2023
SAN DIEGO--(BUSINESS WIRE)--#biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic based therapies for the prevention and treatment of disease, today reported its three and six months ended June 30, 2023 fina...
June 13, 2023
SAN DIEGO--(BUSINESS WIRE)--#biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic based therapies for the prevention and treatment of disease, today announced that the Company has adjourned its 2023 Annual M...
March 13, 2023
SAN DIEGO--(BUSINESS WIRE)--#biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic-based therapies for the prevention and treatment of disease, today announced it has appointed Julia Bohannon, Ph.D. and Anton...
March 6, 2023
SAN DIEGO--(BUSINESS WIRE)--#biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic-based therapies for the prevention and treatment of disease, announced today that its Chief Executive Officer James Rolke wil...
February 14, 2023
SAN DIEGO--(BUSINESS WIRE)--#biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatment of disease, today announced the closing on February 13, 2023...
October 6, 2022
SAN DIEGO--(BUSINESS WIRE)--$REVB #biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic based therapies for the prevention and treatment of disease, today announced an exclusive worldwide license agreement w...
August 15, 2022
15.08.2022 - SAN DIEGO, Aug. 15, 2022 (GLOBE NEWSWIRE) - Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and ...